Mahmoud A. El Hassab

Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations

Wagdy M. Eldehna, Mahmoud A. El Hassab, Mahmoud F. Abo-Ashour et al. · Bioorganic Chemistry · 2021 · 97 citations

Medicinal Chemistry, Medicine, Molecular Dynamics Investigations +10

GC/MS Profiling, Anti-Collagenase, Anti-Elastase, Anti-Tyrosinase and Anti-Hyaluronidase Activities of a Stenocarpus sinuatus Leaves Extract

Mai M. Younis, Iriny M. Ayoub, Nada M. Mostafa et al. · Plants · 2022 · 91 citations · Full text

Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies

Tarfah Al‐Warhi, Al-Aliaa M. Sallam, Loah R. Hemeda et al. · Pharmaceuticals · 2022 · 71 citations · Full text

Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity

Wagdy M. Eldehna, Mahmoud A. El Hassab, Zainab M. Elsayed et al. · Scientific Reports · 2022 · 65 citations · Full text

Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with <i>in vitro</i> antitumor activity towards non-small lung cancer

Esraa A. Abdelsalam, Amer Ali Abd El‐Hafeez, Wagdy M. Eldehna et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 65 citations · Full text